Literature DB >> 25677037

New peptide vaccine for HER2-expressing breast tumors.

Sue Rochman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25677037     DOI： 10.1093/jnci/djv022

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.

Authors:  Atefeh Razazan; Javad Behravan; Atefeh Arab; Nastaran Barati; Leila Arabi; Zahra Gholizadeh; Mahdi Hatamipour; Amin Reza Nikpoor; Amir Abbas Momtazi-Borojeni; Fatemeh Mosaffa; Mohamad Hosein Ghahremani; Mahmoud Reza Jaafari
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

2.  Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

Authors:  Atefeh Razazan; Jessica Nicastro; Roderick Slavcev; Nastaran Barati; Atefeh Arab; Fatemeh Mosaffa; Mahmoud Reza Jaafari; Javad Behravan
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

Review 3.  The Promise of Preventive Cancer Vaccines.

Authors:  Pier-Luigi Lollini; Federica Cavallo; Patrizia Nanni; Elena Quaglino
Journal:  Vaccines (Basel)       Date:  2015-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.